Eli Lilly Urges 9th Circ. Not To Revive Cymbalta Suit

Law360, New York (August 23, 2016, 3:32 PM EDT) -- Eli Lilly and Co. on Monday urged the Ninth Circuit to affirm the denial of class certification and an injunction sought by three consumers accusing the pharmaceutical giant of failing to warn them of antidepressant Cymbalta's withdrawal risk.

Dr. Melissa Strafford, Carol Jacquez and David Matthews Jr. had argued in June that a California federal judge abused his discretion by ordering them to move for certification on their consumer protection law claims in four states without discovery, only to then turn around and conclude the consumers did not put forth sufficient evidence to sustain their claims.

Eli Lilly struck back Monday...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!